Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 46,964	$ 7,402
Prepaid expenses and other current assets	3,500	10,273
Inventory, net		2,225
Total current assets	50,464	19,900
Total assets	50,464	19,900
Current liabilities:
Accounts payable	312,580	530,907
Accounts payable – related party	84,262	282,302
Accrued expenses and other current liabilities	830,983	1,286,119
Accrued expenses – related party	114,297	1,397,409
Deferred revenue – related party	104,782	104,782
Convertible note payable – related party, net of discount, current portion – in default		1,402,000
Convertible notes payable, current portion – in default	200,000	200,000
Notes payable – related parties, current portion – portions in default	497,821	2,783,429
Note payable marketing agreement	450,000	450,000
Derivative liability, current portion	15,282	2,763
Warrant liability	438,972	160,342
Total current liabilities	3,048,979	8,600,053
COMMITMENTS AND CONTINGENCIES (See Note 14)
Series B Preferred stock, 1,000,000 shares designated, 963,964 and 0 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	963,964
Stockholders’ deficit:
Preferred stock, $0.001 par value, 5,000,000 shares authorized: Series A Preferred stock, 150,000 shares designated, 0 and 82,500 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively		83
Common stock, $0.001 par value, 2,000,000,000 shares authorized, 916,914,554 and 111,131,373 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	916,915	111,131
Additional paid-in capital	37,165,114	19,322,864
Accumulated deficit	(42,044,508)	(28,014,231)
Total stockholders’ deficit	(3,962,479)	(8,580,153)
Total liabilities and stockholders’ deficit	$ 50,464	$ 19,900